NO961333L - Nye pyrazolderivater som angiotensin-II-antagonister - Google Patents
Nye pyrazolderivater som angiotensin-II-antagonisterInfo
- Publication number
- NO961333L NO961333L NO961333A NO961333A NO961333L NO 961333 L NO961333 L NO 961333L NO 961333 A NO961333 A NO 961333A NO 961333 A NO961333 A NO 961333A NO 961333 L NO961333 L NO 961333L
- Authority
- NO
- Norway
- Prior art keywords
- angiotensin
- antagonists
- pyrazole derivatives
- novel pyrazole
- compounds
- Prior art date
Links
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title abstract 2
- 229940123413 Angiotensin II antagonist Drugs 0.000 title 1
- 150000003217 pyrazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
Forbindelser med generell formel I og deres salter og solvater er angiotensin II receptorantagonister og kan som sådan brukes ved behandling av hypertensjon, kongestiv hjertesvikt og forhøyet øyetrykk. Oppfinnelsen tilveiebringer også farmasøytiske blandinger som inneholder disse forbindelser foruten fremgangsmåter for deres fremstilling.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09401711A ES2105939B1 (es) | 1994-08-02 | 1994-08-02 | Nuevos pirazoles con actividad antagonista de la angiotensina ii. |
| PCT/EP1995/003086 WO1996004273A1 (en) | 1994-08-02 | 1995-08-02 | New pyrazole derivatives as angiotensin ii antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961333D0 NO961333D0 (no) | 1996-04-01 |
| NO961333L true NO961333L (no) | 1996-04-01 |
Family
ID=8287143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961333A NO961333L (no) | 1994-08-02 | 1996-04-01 | Nye pyrazolderivater som angiotensin-II-antagonister |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5827863A (no) |
| EP (1) | EP0721454A1 (no) |
| JP (1) | JPH09504804A (no) |
| AU (1) | AU3256395A (no) |
| CA (1) | CA2173258A1 (no) |
| ES (1) | ES2105939B1 (no) |
| NO (1) | NO961333L (no) |
| WO (1) | WO1996004273A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| DK1216038T3 (da) * | 1999-08-30 | 2005-12-27 | Sanofi Aventis Deutschland | Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser |
| HU222773B1 (hu) * | 2000-04-21 | 2003-10-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás egy ismert tetrazolszármazék előállítására |
| DE10105916A1 (de) * | 2001-02-09 | 2002-08-22 | Siemens Ag | Amorphe organische 1,3,2-Dioxaborinluminophore, Verfahren zu deren Herstellung und Verwendung davon |
| US7107198B2 (en) * | 2001-11-02 | 2006-09-12 | Sun Microsystems, Inc. | Automatic generation of reduced-size circuit models including inductive interaction |
| WO2008093639A1 (ja) | 2007-01-29 | 2008-08-07 | Takeda Pharmaceutical Company Limited | ピラゾール化合物 |
| JP5833000B2 (ja) * | 2009-07-07 | 2015-12-16 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 二重に作用するピラゾール抗高血圧症薬 |
| CN103772282B (zh) * | 2014-02-26 | 2015-09-23 | 上海毕得医药科技有限公司 | 一种3-叔丁基-1h-吡唑-4-甲醛的制备方法 |
| WO2016035328A1 (ja) * | 2014-09-01 | 2016-03-10 | キヤノン株式会社 | 化合物、分散剤及びトナー |
| AR134016A1 (es) * | 2023-10-06 | 2025-11-26 | Sumitomo Chemical Co | Compuestos de biarilo y método para controlar enfermedades vegetales |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189048A (en) * | 1988-01-07 | 1993-02-23 | E. I. Du Pont De Nemours And Company | Substituted 1,2,3 triazole angiotensin II antagonists |
| GB9005354D0 (en) * | 1990-03-09 | 1990-05-02 | Glaxo Group Ltd | Chemical compounds |
| WO1993005025A1 (en) * | 1991-09-06 | 1993-03-18 | Glaxo Group Limited | C-linked pyrazole derivatives |
| AT398202B (de) * | 1991-10-04 | 1994-10-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
-
1994
- 1994-08-02 ES ES09401711A patent/ES2105939B1/es not_active Expired - Lifetime
-
1995
- 1995-08-02 AU AU32563/95A patent/AU3256395A/en not_active Abandoned
- 1995-08-02 EP EP95929067A patent/EP0721454A1/en not_active Ceased
- 1995-08-02 WO PCT/EP1995/003086 patent/WO1996004273A1/en not_active Ceased
- 1995-08-02 JP JP8506213A patent/JPH09504804A/ja active Pending
- 1995-08-02 CA CA002173258A patent/CA2173258A1/en not_active Abandoned
- 1995-08-02 US US08/624,459 patent/US5827863A/en not_active Expired - Fee Related
-
1996
- 1996-04-01 NO NO961333A patent/NO961333L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5827863A (en) | 1998-10-27 |
| EP0721454A1 (en) | 1996-07-17 |
| WO1996004273A1 (en) | 1996-02-15 |
| CA2173258A1 (en) | 1996-02-15 |
| JPH09504804A (ja) | 1997-05-13 |
| NO961333D0 (no) | 1996-04-01 |
| ES2105939A1 (es) | 1997-10-16 |
| AU3256395A (en) | 1996-03-04 |
| ES2105939B1 (es) | 1998-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051100L (no) | Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer | |
| PH27592A (en) | Imidazolyl-alkenoic acids and its method of use | |
| NO986055L (no) | Nye heterocykliske forbindelser, deres fremstilling, farmas°ytiske preparater inneholdende forbindelsene og deres anvendelse ved behandling av diabetes og beslektede sykdommer | |
| CA2295087A1 (en) | Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | |
| DK5389D0 (da) | Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister | |
| NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
| NO20043531L (no) | Indazolforbindelser som er nyttige som proteinkinaseinhibitorer | |
| DE69011318D1 (de) | Diazinderivate als Angiotensin II Rezeptor Antagonisten. | |
| NO902262L (no) | Fremgangsmaate for fremstilling av azainden-derivater. | |
| NO961333L (no) | Nye pyrazolderivater som angiotensin-II-antagonister | |
| AU641952B2 (en) | Substituted N-(imidazolyl)alkyl alanine derivatives | |
| NO982222L (no) | 3-(4-Subst.-piperidinyl-1)-1-(3,4-diklorfenyl)propylkarbamater og -ureaer og derivater som neurokinin-antagonister | |
| NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
| NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
| NO20052182L (no) | Nye forbindelser | |
| WO1992020651A3 (en) | N-(heteroaryl)-imidazolyl-alkenoic acids | |
| NO931342L (no) | Benzimidazoler, medisinske preparater inneholdende disse,og fremgangsmaate for deres fremstilling | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| NO973340L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme | |
| TW375610B (en) | Novel substituent N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases | |
| NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| NO932002L (no) | Nye tiosemikarbazonsyreestere |